Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $12.88 in the prior trading day, Oscar Health Inc (NYSE: OSCR) closed at $13.22, up 2.64%. In other words, the price has increased by $2.64 from its previous closing price. On the day, 4.16 million shares were traded. OSCR stock price reached its highest trading level at $13.24 during the session, while it also had its lowest trading level at $12.8904.
Ratios:
Our goal is to gain a better understanding of OSCR by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on March 13, 2025, Downgraded its rating to Equal Weight and sets its target price to $16 from $20 previously.
On December 10, 2024, Jefferies started tracking the stock assigning a Underperform rating and target price of $12.
BofA Securities Downgraded its Neutral to Underperform on November 06, 2024, whereas the target price for the stock was revised from $21 to $13.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 10 ’25 when ALESSANDREA QUANE bought 700 shares for $16.50 per share.
ALESSANDREA QUANE bought 5,101 shares of OSCR for $84,181 on Mar 07 ’25. On Mar 05 ’25, another insider, ALESSANDREA QUANE, who serves as the Officer of the company, bought 20,000 shares for $16.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 3312508928 and an Enterprise Value of 1533288064. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36 while its Price-to-Book (P/B) ratio in mrq is 3.27. Its current Enterprise Value per Revenue stands at 0.167 whereas that against EBITDA is 17.149.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.74, which has changed by -0.04410702 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.79, while it has fallen to a 52-week low of $12.43. The 50-Day Moving Average of the stock is -12.72%, while the 200-Day Moving Average is calculated to be -21.37%.
Shares Statistics:
The stock has traded on average 4.62M shares per day over the past 3-months and 5930600 shares per day over the last 10 days, according to various share statistics. A total of 214.97M shares are outstanding, with a floating share count of 175.86M. Insiders hold about 29.81% of the company’s shares, while institutions hold 65.29% stake in the company. Shares short for OSCR as of 1740700800 were 22306293 with a Short Ratio of 4.82, compared to 1738281600 on 19233332. Therefore, it implies a Short% of Shares Outstanding of 22306293 and a Short% of Float of 10.82.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
